Euformatics, a Finnish genomic data startup, today announced that it has closed a seed financing round of 350,000 euros by Tekes and angel investors. The funding is used to expand the global use of Euformatics’s clinical software products. “Next Generation Sequencing unlocks your genomic data, which enables personalised treatment. As the complexity is increasing, hospitals…
Euformatics exposes at stand 49 (Team Finland) at the NHS Innovation Expo in Manchester, September 7th-8th.
From Next-Generation Sequencing to Translational Medicine in Neurological Disease Research Identifying disease-causing genes represents a major focus in current medical genetics research, and next-generation sequencing technology is profoundly changing the way of diagnostics and therapeutics. Coping with the underlying informational complexity requires multidisciplinary efforts that generate synergies through cross-disciplinary research at the nexus of medicine,…
Euformatics and BC Platforms are to deliver the Public Health Genomics Program at Monash University a system to develop and improve methods for storing, retrieving, organising and analysing genomic and clinical data. The program is to tackle an ambitious range of epidemiological, clinical and genetic research questions requiring analysing data sets of increasing size and…
Next-generation sequencing, with other technologies, is enabling the emergence of nucleic acid -based testing in the clinical lab. The article in the MLO July issue touches among other on the reality of the lab bench, technology modifying the scientific approach, and high throughput genetics in medicine.
Euformatics’ partners EMQN and UK NEQAS for Molecular Genetics are currently developing the 2016 quality assessment, which NGS labs will be able to enter in September. This third NGS scheme conducted by the partners will also be a pilot. The hope is to offer a fully-fledged scheme with performance measurements in a couple of years….
This ELIXIR EXCELERATE course, organised by CSC, covers several aspects of variant analysis including variant annotation and prioritisation. The course consists of three independent days, which participants can combine according to their needs. Each course day contains both lectures and hands-on exercises, which are suitable for everybody as analysis is performed with easy-to-use graphical tools. The Euformatics team…
The team from UK NEQAS for Molecular Genetics and the European Molecular Genetics Quality Network EMQN visited Euformatics to prepare for this year’s NGS EQA Pilot scheme. Have you registered for the 2016 EMQN or UK NEQAS pilot?
NGS External Quality Assessment Participants Meeting at ESHG 2016 At the joint UK NEQAS for Molecular Genetics and EMQN Participants meeting the focus was on Next Generation Sequencing (NGS) quality assessment. Part of the external assessment system was using Euformatics’ omnomicsQ QC software platform and Christophe Roos, CSO at Euformatics, will, as one of the…
On the heels of the announcement about the CE mark for Euformatics’ omnomicsNGS tool for genome variant interpretation, Christophe addresses the challenges of building a business around clinical usage of NGS data in an interview with GenomeWeb. The interpretation of gene variants has opened multiple avenues for personalised medicine. Also regular control of quality all…
